A new type of genetic testing saved this Islander's life after his cancer diagnosis

Ryan White was diagnosed with acute myeloid leukemia a few years ago. His sister was ready to donate her bone marrow donor, ...
CURE

Who Should Get Genetic Testing After a Cancer Diagnosis?

Limiting inherited genetic testing to younger people with cancer would have missed most of those who carry a cancer-risk gene ...
WebMD

Decoding Your DNA: What Genetic Testing Can Reveal

Feb. 20, 2025 -- Genetic testing can be both illuminating and intimidating. What exactly is genetic testing, and who might benefit most? We spoke with Huma Q. Rana MD, MPH, Clinical Director of the ...

Expanded genetic testing and early transplant referrals anchor new myelofibrosis care recommendations

The American Society of Hematology (ASH) has released guidelines on the management of myelofibrosis, a rare and ...

Current age-based genetic testing in patients with cancer may miss the majority of inherited gene variants

Germline genetic screening can identify whether a patient with cancer has inherited genetic alterations in a gene or genes ...
Journal of Medical Genetics

UK consensus recommendations for onward testing for Lynch syndrome in patients with deficient mismatch repair (dMMR) non-colorectal/non-endometrial cancers

Background Tumour testing for microsatellite instability (MSI) or mismatch repair deficiency (dMMR) is used to screen for ...
Healthline

What to Know About Transthyretin Amyloidosis (ATTR) Genetic Testing

Genetic testing for ATTR can detect transthyretin mutations and offer crucial information about risk, monitoring, and treatment, if needed. Transthyretin amyloidosis (ATTR) is a genetic condition that ...

Baylor Genetics Study Finds Genome Sequencing Identifies Genetic Diagnoses in Nearly One-Third of Children with Intellectual Disability and Developmental Delay

The retrospective analysis of more than 650 pediatric patients with ID/DD demonstrated that WGS identified a genetic diagnosis in 31.1% of children overall, with the diagnostic yield reaching 35.3% ...
InvestorsHub on MSN

Ambry Genetics launches whole genome sequencing tests to improve rare disease diagnosis

Ambry Genetics, a wholly owned subsidiary of Tempus AI (NASDAQ:TEM), has introduced GenomeNext and GenomeReveal, a new whole ...
newswise

Genetic Testing in Epilepsy: Who, How, and Why?

[00:00:00] Nancy Volkers: Hello listeners, this is the first in a six-episode series on genetic testing and epilepsy. This episode covers the basics of genetic testing and future episodes will dive ...